10 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... Chronic Obstructive Lung ... #Management #Pulmonary ... #COPD #GOLD2017
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
overlap; ICS = ... agonist; LAMA = long-acting ... #Diagnosis #Management ... #Differences #Algorithm ... #Treatment
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... and relief of dyspnea ... Effusions #MPE #Algorithm
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... pulmonary disease (COPD ... squared; CAT, COPD ... #COPD #Treatment ... #Algorithm #Management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... polymicrobial infection ... pain, hemoptysis, dyspnea ... Abscess Management ... polyangiitis) • Malignancy
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
hemoptysis • Dyspnea ... tracheobronchial stenosis, malignancy ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia (COP ... with CTD, drugs, malignancy ... History: cough, dyspnea ... Organizing Pneumonia Treatment ... ILD #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
hemoptysis • Dyspnea ... tracheobronchial stenosis, malignancy ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... Dyspnea 3. ... failure - Infectious ... embolism - Malignancy ... Pulmonary #diagnosis #management